Cargando…
Computational drug repositioning through heterogeneous network clustering
BACKGROUND: Given the costly and time consuming process and high attrition rates in drug discovery and development, drug repositioning or drug repurposing is considered as a viable strategy both to replenish the drying out drug pipelines and to surmount the innovation gap. Although there is a growin...
Autores principales: | Wu, Chao, Gudivada, Ranga C, Aronow, Bruce J, Jegga, Anil G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029299/ https://www.ncbi.nlm.nih.gov/pubmed/24564976 http://dx.doi.org/10.1186/1752-0509-7-S5-S6 |
Ejemplares similares
-
Inferring novel disease indications for known drugs by semantically linking drug action and disease mechanism relationships
por: Qu, Xiaoyan A, et al.
Publicado: (2009) -
Changing Trends in Computational Drug Repositioning
por: Yella, Jaswanth K., et al.
Publicado: (2018) -
GenomeTrafac: a whole genome resource for the detection of transcription factor binding site clusters associated with conventional and microRNA encoding genes conserved between mouse and human gene orthologs
por: Jegga, Anil G., et al.
Publicado: (2007) -
Mining Human Phenome to Investigate Modularity of Complex Disorders
por: Gudivada, Ranga C, et al.
Publicado: (2008) -
PhenoHM: human–mouse comparative phenome–genome server
por: Sardana, Divya, et al.
Publicado: (2010)